Boston Scientific (BSX) Short Interest Ratio & Short Volume → My #1 investment for 2024 (From True Market Insiders) (Ad) Free BSX Stock Alerts $74.65 +0.10 (+0.13%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Boston Scientific Short Interest DataCurrent Short Volume13,940,000 sharesPrevious Short Volume13,160,000 sharesChange Vs. Previous Month+5.93%Dollar Volume Sold Short$1.00 billionShort Interest Ratio / Days to Cover2.2Last Record DateApril 30, 2024Outstanding Shares1,467,100,000 sharesPercentage of Shares Shorted0.95%Today's Trading Volume6,978,299 sharesAverage Trading Volume7,070,820 sharesToday's Volume Vs. Average99% Short Selling Boston Scientific ? Sign up to receive the latest short interest report for Boston Scientific and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBSX Short Interest Over TimeBSX Days to Cover Over TimeBSX Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s PRIME is Set to Shock the WorldMust-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing.Click here for the full story… Boston Scientific Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,940,000 shares $1.00 billion +5.9%N/A2.2 $71.86 4/15/202413,160,000 shares $887.51 million +5.9%N/A2 $67.44 3/31/202412,430,000 shares $851.33 million +8.3%N/A1.9 $68.49 3/15/202411,480,000 shares $760.32 million +21.6%N/A1.8 $66.23 2/29/20249,440,000 shares $625.02 million -14.4%N/A1.5 $66.21 2/15/202411,030,000 shares $728.97 million +1.5%N/A1.7 $66.09 Get the Latest News and Ratings for BSX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. 1/31/202410,870,000 shares $687.64 million -4.9%N/A1.6 $63.26 1/15/202411,430,000 shares $685.11 million +22.3%N/A1.7 $59.94 12/31/20239,350,000 shares $540.52 million -19.7%N/A1.3 $57.81 12/15/202311,640,000 shares $649.63 million +26.0%N/A1.6 $55.81 11/30/20239,240,000 shares $516.42 million -22.0%N/A1.2 $55.89 11/15/202311,850,000 shares $638.12 million +29.7%N/A1.4 $53.85 10/31/20239,140,000 shares $467.88 million -32.3%N/A1.1 $51.19 10/15/202313,490,000 shares $668.02 million -7.5%N/A1.6 $49.52 9/30/202314,580,000 shares $769.82 million +22.7%N/A1.9 $52.80 9/15/202311,880,000 shares $628.45 million -2.8%N/A1.6 $52.90 8/31/202312,220,000 shares $659.15 million +40.1%N/A1.7 $53.94 8/15/20238,720,000 shares $450.65 million +4.7%N/A1.2 $51.68 7/31/20238,330,000 shares $431.91 million +13.2%N/A1.1 $51.85 7/15/20237,360,000 shares $390.30 million -13.2%N/A0.9 $53.03 6/30/20238,480,000 shares $458.51 million -2.8%N/A1 $54.07 6/15/20238,720,000 shares $470.79 million -29.5%N/A1 $53.99 5/31/202312,360,000 shares $636.29 million -23.0%N/A1.3 $51.48 5/15/202316,050,000 shares $861.56 million -10.7%N/A1.8 $53.68 4/30/202317,970,000 shares $936.60 million +16.4%N/A2.1 $52.12 4/15/202315,440,000 shares $799.33 million +1.9%N/A1.9 $51.77 3/31/202315,160,000 shares $758.45 million +5.9%N/A1.9 $50.03 3/15/202314,310,000 shares $686.45 million +12.8%N/A2 $47.97 2/28/202312,690,000 shares $592.88 million +29.9%N/A1.8 $46.72 2/15/20239,770,000 shares $462.02 million -26.2%N/A1.5 $47.29 1/31/202313,230,000 shares $611.89 million -15.3%N/A2 $46.25 1/15/202315,610,000 shares $726.33 million +10.6%N/A2.3 $46.53 12/30/202214,110,000 shares $652.87 million -1.7%N/A2.1 $46.27 12/15/202214,350,000 shares $664.69 million +8.8%N/A2.1 $46.32 11/30/202213,190,000 shares $597.11 million +0.2%N/A1.9 $45.27 11/15/202213,170,000 shares $558.67 million -5.3%N/A1.9 $42.42 10/31/202213,910,000 shares $599.66 million -8.6%N/A2 $43.11 10/15/202215,220,000 shares $608.50 million -8.8%N/A2.2 $39.98 9/30/202216,690,000 shares $646.40 million +3.7%N/A2.5 $38.73 9/15/202216,100,000 shares $679.42 million +5.9%N/A2.4 $42.20[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. BSX Short Interest - Frequently Asked Questions What is Boston Scientific's current short interest? Short interest is the volume of Boston Scientific shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 13,940,000 shares of BSX short. Learn More on Boston Scientific's current short interest. What is a good short interest ratio for Boston Scientific? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BSX shares currently have a short interest ratio of 2.0. Learn More on Boston Scientific's short interest ratio. Which institutional investors are shorting Boston Scientific? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, JPMorgan Chase & Co., SG Americas Securities LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Caas Capital Management LP, Valeo Financial Advisors LLC, Valeo Financial Advisors LLC, Curated Wealth Partners LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Boston Scientific's short interest increasing or decreasing? Boston Scientific saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 13,940,000 shares, an increase of 5.9% from the previous total of 13,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Boston Scientific's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Boston Scientific: Stryker Co. (1.19%), Becton, Dickinson and Company (0.75%), DexCom, Inc. (2.79%), ResMed Inc. (6.70%), Regeneron Pharmaceuticals, Inc. (1.42%), Vertex Pharmaceuticals Incorporated (1.50%), Medtronic plc (1.05%), The Cigna Group (1.22%), GSK plc (0.44%), Elevance Health, Inc. (0.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Boston Scientific stock? Short selling BSX is an investing strategy that aims to generate trading profit from Boston Scientific as its price is falling. BSX shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Boston Scientific? A short squeeze for Boston Scientific occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BSX, which in turn drives the price of the stock up even further. How often is Boston Scientific's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SYK Short Squeeze BDX Short Squeeze DXCM Short Squeeze RMD Short Squeeze REGN Short Squeeze VRTX Short Squeeze MDT Short Squeeze CI Short Squeeze GSK Short Squeeze ELV Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BSX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics